IN2014DN06573A - - Google Patents

Info

Publication number
IN2014DN06573A
IN2014DN06573A IN6573DEN2014A IN2014DN06573A IN 2014DN06573 A IN2014DN06573 A IN 2014DN06573A IN 6573DEN2014 A IN6573DEN2014 A IN 6573DEN2014A IN 2014DN06573 A IN2014DN06573 A IN 2014DN06573A
Authority
IN
India
Prior art keywords
modafinil
fluid
pharmaceutical composition
substrate
solubilizing
Prior art date
Application number
Other languages
English (en)
Inventor
Christophe Lebon
Pascal Suplie
Fabrice Leboeuf
Jennifer Jung
Frantz Deschamps
Original Assignee
Debregeas Et Associes Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Debregeas Et Associes Pharma filed Critical Debregeas Et Associes Pharma
Publication of IN2014DN06573A publication Critical patent/IN2014DN06573A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Closures For Containers (AREA)
IN6573DEN2014 2012-02-28 2013-02-25 IN2014DN06573A (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1200580A FR2987266B1 (fr) 2012-02-28 2012-02-28 Procede d'obtention d'une composition pharmaceutique a base de modafinil, composition pharmaceutique ainsi obtenue et son application
PCT/FR2013/000051 WO2013128087A1 (fr) 2012-02-28 2013-02-25 Procédé d'obtention d'une composition pharmaceutique à base de modafinil, composition pharmaceutique ainsi obtenue et son application

Publications (1)

Publication Number Publication Date
IN2014DN06573A true IN2014DN06573A (pl) 2015-06-26

Family

ID=48083446

Family Applications (1)

Application Number Title Priority Date Filing Date
IN6573DEN2014 IN2014DN06573A (pl) 2012-02-28 2013-02-25

Country Status (31)

Country Link
US (1) US9782367B2 (pl)
EP (1) EP2819654B1 (pl)
JP (1) JP6026566B2 (pl)
KR (1) KR101911989B1 (pl)
CN (1) CN104168889B (pl)
AR (1) AR090168A1 (pl)
AU (1) AU2013224830B2 (pl)
CA (1) CA2863042A1 (pl)
CL (1) CL2014002202A1 (pl)
CY (1) CY1117049T1 (pl)
DK (1) DK2819654T3 (pl)
EA (1) EA024459B1 (pl)
ES (1) ES2554794T3 (pl)
FR (1) FR2987266B1 (pl)
HR (1) HRP20151280T1 (pl)
HU (1) HUE027141T2 (pl)
IL (1) IL234008A (pl)
IN (1) IN2014DN06573A (pl)
MA (1) MA37284B1 (pl)
MX (1) MX349970B (pl)
NZ (1) NZ628007A (pl)
PH (1) PH12014501838A1 (pl)
PL (1) PL2819654T3 (pl)
PT (1) PT2819654E (pl)
RS (1) RS54435B1 (pl)
SG (1) SG11201404812QA (pl)
SI (1) SI2819654T1 (pl)
SM (1) SMT201600029B (pl)
TW (1) TWI543779B (pl)
UA (1) UA113539C2 (pl)
WO (1) WO2013128087A1 (pl)

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5618845A (en) 1994-10-06 1997-04-08 Cephalon, Inc. Acetamide derivative having defined particle size
CN1249932A (zh) * 1999-09-29 2000-04-12 付俊昌 一种莫达芬尼及其光学对映体l及d异构体的新用途
EP1263413B1 (en) * 2000-03-09 2006-05-24 Ohio State University Research Foundation Method of preparing solid dispersions
US6919378B2 (en) 2000-10-11 2005-07-19 Cephalon, Inc. Pharmaceutical solutions of modafinil compounds
US6489363B2 (en) 2000-10-11 2002-12-03 Cephalon, Inc. Pharmaceutical solutions of modafinil compounds
US7297346B2 (en) 2001-05-25 2007-11-20 Cephalon Inc. Pharmaceutical formulations of modafinil
US20040048931A1 (en) 2002-07-12 2004-03-11 Craig Heacock Modafinil pharmaceutical compositions
US20040121003A1 (en) 2002-12-19 2004-06-24 Acusphere, Inc. Methods for making pharmaceutical formulations comprising deagglomerated microparticles
US20060024370A1 (en) * 2004-07-29 2006-02-02 Cephalon France Modafinil oral lyophilizate
GB0523653D0 (en) * 2005-11-21 2005-12-28 Novartis Ag Organic compounds
PL1909973T3 (pl) * 2005-07-15 2019-01-31 Micell Technologies, Inc. Polimerowe powłoki zawierające proszek leku o kontrolowanej morfologii
WO2007013962A2 (en) * 2005-07-21 2007-02-01 Neurohealing Pharmaceuticals, Inc. Rapid onset and short term modafinil compositions and methods of use thereof
MX2009000391A (es) * 2006-07-12 2009-06-30 Elan Pharma Int Ltd Formulación de modafinilo en forma de nano-partículas.
US8173169B2 (en) * 2007-07-11 2012-05-08 Hikma Pharmaceuticals Formulation and process for the preparation of modafinil
FR2943543B1 (fr) 2009-03-31 2013-02-08 Separex Sa Procede de preparation de compositions pharmaceutiques comprenant des particules fines de substance active.
KR100924236B1 (ko) * 2009-06-23 2009-10-29 충남대학교산학협력단 균일한 입도분포를 가지는 초미세입자의 신규한 제조방법 및 장치

Also Published As

Publication number Publication date
EP2819654B1 (fr) 2015-09-09
KR101911989B1 (ko) 2018-10-25
ES2554794T3 (es) 2015-12-23
MA20150242A2 (fr) 2015-07-31
AU2013224830B2 (en) 2017-02-02
FR2987266B1 (fr) 2014-12-19
DK2819654T3 (en) 2015-12-21
CN104168889B (zh) 2016-10-26
UA113539C2 (xx) 2017-02-10
MA37284B1 (fr) 2016-06-30
CY1117049T1 (el) 2017-04-05
IL234008A (en) 2017-02-28
AU2013224830A1 (en) 2014-08-21
US9782367B2 (en) 2017-10-10
EP2819654A1 (fr) 2015-01-07
JP6026566B2 (ja) 2016-11-16
MX2014010236A (es) 2015-04-09
JP2015508804A (ja) 2015-03-23
SI2819654T1 (sl) 2015-12-31
PT2819654E (pt) 2015-12-21
HK1198931A1 (en) 2015-06-19
EA024459B1 (ru) 2016-09-30
WO2013128087A1 (fr) 2013-09-06
US20150105470A1 (en) 2015-04-16
CA2863042A1 (fr) 2013-09-06
IL234008A0 (en) 2014-09-30
FR2987266A1 (fr) 2013-08-30
SMT201600029B (it) 2016-02-25
RS54435B1 (sr) 2016-06-30
PH12014501838B1 (en) 2014-11-10
PL2819654T3 (pl) 2016-02-29
SG11201404812QA (en) 2014-10-30
KR20140129035A (ko) 2014-11-06
MX349970B (es) 2017-08-23
HRP20151280T1 (hr) 2016-01-01
NZ628007A (en) 2015-07-31
EA201400962A1 (ru) 2014-12-30
CN104168889A (zh) 2014-11-26
PH12014501838A1 (en) 2014-11-10
TWI543779B (zh) 2016-08-01
TW201340995A (zh) 2013-10-16
AR090168A1 (es) 2014-10-22
CL2014002202A1 (es) 2015-03-13
HUE027141T2 (hu) 2016-08-29

Similar Documents

Publication Publication Date Title
MX365294B (es) Inhibidores de proteína cinasa dependiente de adn.
SMT202100259T1 (it) 4'-fluoro-nucleosidi, 4'-fluoro-nucleotidi e loro analoghi per il trattamento di hcv s
WO2012106356A3 (en) Virus-like particles and methods of use
WO2012096929A3 (en) Heteroaryl compounds and methods of use thereof
GB201304564D0 (en) Novel removable clothing
MA39710A (fr) Composition topique destinée à être utilisée dans le traitement d'une maladie inflammatoire de l'intestin
IN2013MU03583A (pl)
MX2014005440A (es) Inhibidores de nicotinamida adenina dinucleotido difosfato oxidasa-4 y uso de los mismos.
CL2014001838A1 (es) Compuestos derivados de fluormetil-5,6-dihidro-4h-[1,3]oxazin-2-ilamina, como inhibidores de la bace1; su proceso de obtencion; composicion farmaceutica que los contiene; y su uso para el tratamiento terapeutico y/o profilactico de la enfermedad de alzheimer, esclerosis lateral amiotrofica, cancer, enfermedades cardiovasculares y enfermedades gastrointestinales, entre otras.
HUE059279T2 (hu) Eljárás alkének elõállítására és azok felhasználása 1,3-butadién elõállításához
IN2014MN02236A (pl)
MX2015012526A (es) Inhibodores macrociclicos de cinasa rip2.
CL2014003607A1 (es) Compuestos derivados de benzodioxol, inhibidores de la acetilcolinesterasa; metodo de preparacion; compuestos intermediarios; composicion farmaceutica; y uso en la prevencion o el tratamiento de la enfermedad de alzheimer.
CL2015001391A1 (es) Compuestos derivados de hidantoina, análogo de pth; composicion farmaceutica; metodo para la prevencion o el tratamieno de osteoporosis,fracturas, hipocondroplasia; y su uso para la produccion de un agente movilizador de celulas madre o un agente para prevenir o tratar osteoporosis, entre otras
NZ702239A (en) Heteroaryl compounds and methods of use thereof
MY186523A (en) Macrocyclic rip2 kinase inhibitors
MX2016008968A (es) Compuestos organicos.
CL2015001881A1 (es) Compuesto 4-hidroxi-2-metil-5-(propan-2-iliden)ciclohexil-3-en-1-carbaldehido; uso del compuesto para el tratamiento de la enfermedad de alzheimer; composición farmacéutica; método para preparar la composición.
WO2014197536A3 (en) Novel beta lactams as modulators of glutamate uptake and methods for use thereof
IN2014DN06573A (pl)
MX374598B (es) Complejo de tanato de sitagliptina.
WO2013038200A3 (en) Neurodevelopmental disorders
PH12016501808A1 (en) Chemical compounds
WO2015200768A3 (en) Pharmacologic treatments of menière's disease
FI20145806A7 (fi) Valmisteet alkoholipunoituksen ja alkoholin indusoimien yliherkkyysreaktioiden hoitamiseksi ja ehkäisemiseksi